Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2006460415;60416;60417 chr2:178591629;178591628;178591627chr2:179456356;179456355;179456354
N2AB1842355492;55493;55494 chr2:178591629;178591628;178591627chr2:179456356;179456355;179456354
N2A1749652711;52712;52713 chr2:178591629;178591628;178591627chr2:179456356;179456355;179456354
N2B1099933220;33221;33222 chr2:178591629;178591628;178591627chr2:179456356;179456355;179456354
Novex-11112433595;33596;33597 chr2:178591629;178591628;178591627chr2:179456356;179456355;179456354
Novex-21119133796;33797;33798 chr2:178591629;178591628;178591627chr2:179456356;179456355;179456354
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACT
  • RefSeq wild type template codon: TGA
  • Domain: Fn3-33
  • Domain position: 88
  • Structural Position: 124
  • Q(SASA): 0.2234
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/A None None 0.997 N 0.709 0.267 0.261217442401 gnomAD-4.0.0 1.59225E-06 None None None None N None 5.66572E-05 0 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.3169 likely_benign 0.2682 benign -0.878 Destabilizing 0.997 D 0.709 prob.delet. N 0.476456034 None None N
T/C 0.8547 likely_pathogenic 0.8582 pathogenic -0.525 Destabilizing 1.0 D 0.755 deleterious None None None None N
T/D 0.9568 likely_pathogenic 0.946 pathogenic -1.371 Destabilizing 0.999 D 0.825 deleterious None None None None N
T/E 0.9633 likely_pathogenic 0.9545 pathogenic -1.146 Destabilizing 0.999 D 0.832 deleterious None None None None N
T/F 0.9674 likely_pathogenic 0.9573 pathogenic -0.455 Destabilizing 0.999 D 0.789 deleterious None None None None N
T/G 0.6834 likely_pathogenic 0.6432 pathogenic -1.323 Destabilizing 0.999 D 0.737 deleterious None None None None N
T/H 0.9604 likely_pathogenic 0.955 pathogenic -1.454 Destabilizing 1.0 D 0.746 deleterious None None None None N
T/I 0.8837 likely_pathogenic 0.8544 pathogenic 0.298 Stabilizing 0.999 D 0.815 deleterious N 0.479245623 None None N
T/K 0.974 likely_pathogenic 0.9659 pathogenic -0.4 Destabilizing 0.999 D 0.827 deleterious None None None None N
T/L 0.6313 likely_pathogenic 0.5756 pathogenic 0.298 Stabilizing 0.998 D 0.804 deleterious None None None None N
T/M 0.511 ambiguous 0.4447 ambiguous 0.183 Stabilizing 1.0 D 0.747 deleterious None None None None N
T/N 0.795 likely_pathogenic 0.7562 pathogenic -1.173 Destabilizing 0.999 D 0.809 deleterious N 0.472833134 None None N
T/P 0.8491 likely_pathogenic 0.8142 pathogenic -0.062 Destabilizing 0.999 D 0.79 deleterious N 0.457387484 None None N
T/Q 0.9468 likely_pathogenic 0.9343 pathogenic -0.841 Destabilizing 0.999 D 0.785 deleterious None None None None N
T/R 0.9648 likely_pathogenic 0.9562 pathogenic -0.736 Destabilizing 0.999 D 0.797 deleterious None None None None N
T/S 0.2749 likely_benign 0.2579 benign -1.365 Destabilizing 0.997 D 0.733 deleterious N 0.466028397 None None N
T/V 0.6345 likely_pathogenic 0.5942 pathogenic -0.062 Destabilizing 0.998 D 0.818 deleterious None None None None N
T/W 0.994 likely_pathogenic 0.9927 pathogenic -0.725 Destabilizing 1.0 D 0.763 deleterious None None None None N
T/Y 0.9782 likely_pathogenic 0.9733 pathogenic -0.285 Destabilizing 1.0 D 0.791 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.